Consistent with increased frequency of CD4+CD25+Treg cells with indirubin treatment, we observed a significant increase of CD4+CD25+Foxp3+Treg cells indirubin-treated ITP mice (P<0.01, Fig 2D). This evidence concerns the gene CD4 and autoimmune thrombocytopenic purpura.